Project Twenty21

Drug Science launched Europe’s first and biggest national medical cannabis registry, called Project Twenty21, on the 7th November 2019. Project TWENTY21 will enrol 20,000 patients by the end of 2021, creating the largest body of evidence for the effectiveness and tolerability of medical cannabis – with an aim to demonstrate to policymakers that medical cannabis  …


Statement on the dangers posed by e-cigarettes

Drug Science stands by its e-cigarette analysis from 2014, any way of radically reducing the death toll from tobacco would be a worldwide public health triumph. e-cigarettes are not the solution to end the ever-increasing death toll caused by tobacco. However, they have proven to be an incredibly effective tool for tens of thousands of  …


Press Release: Government decision on cannabis-related medicinal products draws criticism from independent scientific body, Drug Science.

Today (13th August 2019), the independent scientific body Drug Science has responded with disappointment to a decision by the National Institute for Health and Care Excellence (NICE), relating to cannabis-related medical products. In November 2018, the then Home Secretary Sajid Javid introduced regulations so that cannabis-derived medicinal products would be available on prescription. This change  …


First safety study of MDMA-assisted psychotherapy in patients with alcohol use disorder

Read the full paper here (open access) We present the preliminary data in the Bristol-Imperial MDMA-for-Alcoholism (BIMA) study, an ongoing open-label safety and tolerability proof of concept study exploring the potential role for 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in treating patients with alcohol use disorder (AUD). At this stage, eleven participants have completed the full 8-week MDMA-assisted  …


UK General Election 2019 - Political party positions on drugs

With the 2019 general election fast approaching, a lot of media coverage will focus on each party’s Brexit policies. Drug Science would like to offer a different perspective, what do the six highest polling parties promise to do to address the UK’s failing drug policy. This is what each party has publicly announced relating to  …


Response to the Nature article: Moving from prison to PhD

There are fewer than ten empirical studies on the transition from prison to university so the article “Moving from Prison to PhD” is a step in the right direction to highlight this neglected and important topic. Globally, millions of individuals are arrested and charged with drug offences every year. Most of them will be scarred  …


Statement on the dangers posed by e-cigarettes

Drug Science stands by its e-cigarette analysis from 2014, any way of radically reducing the death toll from tobacco would be a worldwide public health triumph. e-cigarettes are not the solution to end the ever-increasing death toll caused by tobacco. However, they have proven to be an incredibly effective tool for tens of thousands of  …


New Zealand revises sentencing framework for methamphetamine offences

Dr James Foulds, Consultant forensic psychiatrist, Christchurch New Zealand Methamphetamine smoking is the commonest form of stimulant use in New Zealand. Asian importation has increased recently, and the drug has got much cheaper. However, despite harsh sanctions, dealing remains attractive for many people- including those who sell the drug to fund their own use. Until  …


Statement on the dangers posed by e-cigarettes

Drug Science stands by its e-cigarette analysis from 2014, any way of radically reducing the death toll from tobacco would be a worldwide public health triumph. e-cigarettes are not the solution to end the ever-increasing death toll caused by tobacco. However, they have proven to be an incredibly effective tool for tens of thousands of  …


First safety study of MDMA-assisted psychotherapy in patients with alcohol use disorder

Read the full paper here (open access) We present the preliminary data in the Bristol-Imperial MDMA-for-Alcoholism (BIMA) study, an ongoing open-label safety and tolerability proof of concept study exploring the potential role for 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in treating patients with alcohol use disorder (AUD). At this stage, eleven participants have completed the full 8-week MDMA-assisted  …


Project Twenty21 – Scientific Oversight Board

Project Twenty21 is committed to scientific excellence and the development of independent scientific evidence. It is supported by a scientific oversight board, consisting of the following expertise:   Professor David Nutt DM, FRCP, FRCPSYCH, FSB, FMEDSCI. Professor of Neuropsychopharmacology at Imperial College London. Professor Eileen Joyce MA, PhD, MB BChir, MRCP, FRCPsych Professor of Neuropsychiatry  …